Registry of the Spanish network of Behçet's disease: A descriptive analysis of 496 patients

Clinical and Experimental Rheumatology

Volumn 32, Issue , 2014, Pages S33-S39

  Rodríguez Carballeira, Mónica ^a   Alba, Marco A ^b   Solans Laqué, Roser ^c   Castillo, María Jesús ^d   Ríos Fernández, Raquel ^e   Larrañaga, José Ramón ^f   Martínez Berriotxoa, Agustín ^g   Espinosa, Gerard ^b   Mejía, Juan Carlos ^b   Martínez Valle, Ferran ^c   Munté, Enric ^c   Callejas, José Luis ^e   González, Rocío ^d   Vidaller, Antonio ^h   Solanich, Xavier ^h   Trapiella, Luis ⁱ   de la Torre, Ricardo Gómez ⁱ   Herranz, María Teresa ^j   Todolí, José ^k   Fraile, Guadalupe ^l   Muñoz Rodríguez, Francisco José ^m   Fanlo, Patricia ⁿ   García Sánchez, Isabel ^o   Fonseca, Eva ^p   more..

^a Hospital Universitario Mutua Terrasa   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^e HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^f UNIVERSITY HOSPITAL COMPLEX OF VIGO   (Spain)

^g HOSPITAL DE CRUCES   (Spain)

^h HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

ⁱ HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^j HOSPITAL MORALES MESEGUER   (Spain)

^k HOSPITAL UNIVERSITARIO LA FE   (Spain)

^l HOSPITAL RAMÓN Y CAJAL   (Spain)

^m Hospital de Mollet   (Spain)

ⁿ Instituto de Investigación Sanitaria de Navarra   (Spain)

^o HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

^p HOSPITAL DE CABUEÑES   (Spain)

more..

Author keywords

Beh et's disease; Gender; Spain

Indexed keywords

ANTICOAGULANT AGENT; ANTIMALARIAL AGENT; AZATHIOPRINE; BIOLOGICAL PRODUCT; CHLORAMBUCIL; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PENTOXIFYLLINE; THALIDOMIDE; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; AGED; ANEURYSM; ARTHRITIS; ARTICLE; ASEPTIC MENINGITIS; ASEPTIC NECROSIS; BEHCET DISEASE; BRAIN PSEUDOTUMOR; CATARACT; CAUCASIAN; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; COHORT ANALYSIS; DEMOGRAPHY; DIABETES MELLITUS; DISEASE COURSE; DISEASE REGISTRY; ERYTHEMA NODOSUM; EYE INFLAMMATION; FAMILY HISTORY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GENITAL ULCER; GEOGRAPHIC DISTRIBUTION; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; IRIDOCYCLITIS; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; ONSET AGE; OSTEOPENIA; PERIPHERAL NEUROPATHY; PREVALENCE; PSEUDOFOLLICULITIS; RETINA VASCULITIS; RETROSPECTIVE STUDY; SEX DIFFERENCE; SEX RATIO; SKIN DISEASE; SPANIARD; URINARY TRACT INFECTION; VEIN THROMBOSIS; ARAB; BEHCET SYNDROME; BLACK PERSON; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; ETHNOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; REGISTER; SEXUAL DEVELOPMENT; SPAIN; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ARABS; BEHCET SYNDROME; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PREVALENCE; REGISTRIES; RETROSPECTIVE STUDIES; SEX CHARACTERISTICS; SPAIN; YOUNG ADULT;

EID: 84907550048     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. SAKANE T, TAKENO M, SUZUKI N, INABA G: Behçet's disease. N Engl J Med 1999; 341: 1284-91.
2. JENNETTE JC, FALK RJ, BACON PA et al.: 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 2013; 65: 1-11.
3. HATEMI G, SEYAHI E, FRESKO I, HAMURY-UDAN V: Behçet's syndrome: a critical digest of the recent literature. Clin Exp Rheumatol 2012; 30: S80-9.
4. RICART JM, TODOLI J, VILATA JJ et al.: [Behçet disease: study of 74 patients]. Med Clin (Barc) 2006; 127: 496-9.
5. ROUX H, RICHARD P, ARRIGHI A, BERGAOUI N: [Autochthonous Behçet's disease. Apropos of 73 cases]. Rev Rhum Mal Osteoartic 1989; 56: 383-8.
6. BANG D, LEE JH, LEE ES et al.: Epidemiologic and clinical survey of Behçet's disease in Korea: the first multicenter study. J Korean Med Sci 2001; 16: 615-8.
7. CALAMIA KT, WILSON FC, ICEN M, CROWSON CS, GABRIEL SE, KREMERS HM: Epidemiology and clinical characteristics of Behçet's disease in the US: a population-based study. Arthritis Rheum 2009; 61: 600-4.
8. CHAJEK T, FAINARU M: Behçet's disease. Report of 41 cases and a review of the literature. Medicine (Baltimore) 1975; 54: 179-96.
9. OLIVIERI I, LECCESE P, PADULA A et al.: High prevalence of Behçet's disease in southern Italy. Clin Exp Rheumatol 2013; 31 (Suppl. 77): S28-31
10. SALVARANI C, PIPITONE N, CATANOSO MG et al.: Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study. Arthritis Rheum 2007; 57: 171-8.
11. GURLER A, BOYVAT A, TURSEN U: Clinical manifestations of Behçet's disease: an analysis of 2147 patients. Yonsei Med J 1997; 38: 423-7.
12. DE SOUZA-RAMALHO P, D'ALMEIDA MF, FREITAS JP, PINTO J: Behçet's disease in Portugal. Acta Med Port 1991; 4: 79-82.
13. KRAUSE I, YANKEVICH A, FRASER A et al.: Prevalence and clinical aspects of Behçet's disease in the north of Israel. Clin Rheumatol 2007; 26: 555-60.
14. ALTENBURG A, PAPOUTSIS N, ORAWA H, MARTUS P, KRAUSE L, ZOUBOULIS CC: [Epidemiology and clinical manifestations of Adamantiades-Behçet disease in Germany-current pathogenetic concepts and therapeutic possibilities]. J Dtsch Dermatol Ges 2006; 4: 49-64; quiz 5-6.
15. MIZUSHIMA Y: Recent research into Behçet's disease in Japan. Int J Tissue React 1988; 10: 59-65.
16. ZOUBOULIS CC, KOTTER I, DJAWARI D et al.: Epidemiological features of Adamantiades-Behçet's disease in Germany and in Europe. Yonsei Med J 1997; 38: 411-22.
17. ZOUBOULIS CH C, KOTTER I, DJAWARI D et al.: Current epidemiological data from the German Registry of Adamantiades-Behçet's disease. Adv Exp Med Biol 2003; 528: 43-8.
18. DAVATCHI F, SHAHRAM F, CHAMS-DAVATCHI C et al.: Behçet's disease in Iran: analysis of 6500 cases. Int J Rheum Dis 2010; 13: 367-73.
19. DAVATCHI F, SHAHRAM F, SHAMS H et al.: Gender influence on ocular manifestations and their outcome in Behçet's Disease. A long-term follow-up of up to 20 years. Clin Rheumatol 2011; 30: 541-7.
20. TURSEN U, GURLER A, BOYVAT A: Evaluation of clinical findings according to sex in 2313 Turkish patients with Behçet's disease. Int J Dermatol 2003; 42: 346-51.
21. DAVATCHI F, SHAHRAM F, CHAMS-DAVATCHI C et al.: Behçet's disease: is there a gender influence on clinical manifestations? Int J Rheum Dis 2012; 15: 306-14.
22. KURAL-SEYAHI E, FRESKO I, SEYAHI N et al.: The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 2003; 82: 60-76.
23. CRITERIA FOR DIAGNOSIS OF BEHçET'S DISEASE: International Study Group for Behçet's Disease. Lancet 1990; 335: 1078-80.
24. OLIVEIRA AC, BUOSI AL, DUTRA LA, DeE SOUZA AW: Behçet disease: clinical features and management in a Brazilian tertiary hospital. J Clin Rheumatol 2011; 17: 416-20.
25. AKMAN-DEMIR G, SERDAROGLU P, TASCI B: Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group. Brain 1999; 122: 2171-82.
26. SBAI A, WECHSLER B, DUHAUT P et al.: Neuro-Behçet's disease (isolated cerebral thrombophlebitis excluded). Clinical pattern, prognostic factors, treatment and long term follow-up. Adv Exp Med Biol 2003; 528: 371-6.
27. HATEMI G, SILMAN A, BANG D et al.: EULAR recommendations for the management of Behçet disease. Ann Rheum Dis 2008; 67: 1656-62.
28. BAIXAULI A, CALVO J, TAMARIT JJ, CAMPOS C, GARCIA S, HERRERA A: [Behçet's disease: retrospective study]. An Med Interna 2001; 18: 405-10.
29. PERRA D, ALBA MA, CALLEJAS JL et al.: Adalimumab for the treatment of Behçet's disease: experience in 19 patients. Rheumatology (Oxford) 2012; 51: 1825-31.
30. ZHANG YJ, XU WD, DUAN ZH, LIU SS, PAN HF, YE DQ: Lack of association between CTLA-4 +49A/G and-318C/T polymorphisms and Behçet's disease risk: a meta-analysis. Clin Exp Rheumatol 2012; 30: S46-50.
31. TALARICO R, D'ASCANIO A, FIGUS M et al.: Behçet's disease: features of neurological involvement in a dedicated centre in Italy. Clin Exp Rheumatol 2012; 30: S69-72.
32. ZOUBOULIS CC, VAIOPOULOS G, MARCO-MICHELAKIS N et al.: Onset signs, clinical course, prognosis, treatment and outcome of adult patients with Adamantiades-Behçet's disease in Greece. Clin Exp Rheumatol 2003; 21: S19-26.
33. DAVATCHI F, SHAHRAM F, CHAMS H et al.: The influence of gender on the severity and the outcome of ocular lesions in Behçet's disease. Adv Exp Med Biol 2003; 528: 67-71.
34. BENAMOUR S, NAJI T, ALAOUI FZ, EL-KABLI H, EL-AIDOUNI S: [Neurological involvement in Behçet's disease. 154 cases from a cohort of 925 patients and review of the literature]. Rev Neurol (Paris) 2006; 162: 1084-90.
35. AMES PR, STEUER A, PAP A, DENMAN AM: Thrombosis in Behçet's disease: a retrospective survey from a single UK centre. Rheumatology (Oxford) 2001; 40: 652-5.
36. DUZGUN N, ATES A, AYDINTUG OT, DEMIR O, OLMEZ U: Characteristics of vascular involvement in Behçet's disease. Scand J Rheumatol 2006; 35: 65-8.
37. KWON TW, PARK SJ, KIM HK, YOON HK, KIM GE, YU B: Surgical treatment result of abdominal aortic aneurysm in Behçet's disease. Eur J Vasc Endovasc Surg 2008; 35: 173-80.
38. YAZICI H, BASARAN G, HAMURYUDAN V et al.: The ten-year mortality in Behçet's syndrome. Br J Rheumatol 1996; 35: 139-41.
39. YAZICI H, TUZUN Y, TANMAN AB et al.: Male patients with Behçet's syndrome have stronger pathergy reactions. Clin Exp Rheumatol 1985; 3: 137-41.
40. PIPITONE N, BOIARDI L, OLIVIERI I et al.: Clinical manifestations of Behçet's disease in 137 Italian patients: results of a multicenter study. Clin Exp Rheumatol 2004; 22: S46-51.
41. DEMIROGLU H, BARISTA I, DUNDAR S: Risk factor assessment and prognosis of eye involvement in Behçet's disease in Turkey. Ophthalmology 1997; 104: 701-5.
42. YAZICI H, TUZUN Y, PAZARLI H et al.: Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behçet's syndrome. Ann Rheum Dis 1984; 43: 783-9.
43. HAMURYUDAN V, HATEMI G, SUT N, UGURLU S, YURDAKUL S, YAZICI H: Frequent oral ulceration during early disease may predict a severe disease course in males with Behcçet's syndrome. Clin Exp Rheumatol 2012; 30: S32-4.
44. VANDERPUMP MP, TUNBRIDGE WM, FRENCH JM et al.: The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxford) 1995; 43: 55-68.
45. BOURA P, TSELIOS K, SKENDROS P, KAMALI S, SARANTOPOULOS A, RAPTOPOULOU-GIGI M: Adamantiades-Behçet disease (ABD) in northern Greece patients: experience from a single center. Hippokratia 2007; 11: 210-5.
46. DIANATI B, SALIBA S, ETIENNE G et al.: Clinical presentation of Behçet's disease in internal medicine. Adv Exp Med Biol 2003; 528: 81-2.
47. YANG P, FANG W, MENG Q, REN Y, XING L, KIJLSTRA A: Clinical features of chinese patients with Behçet's disease. Ophthalmology 2008; 115: 312-8 e4.